GoingToMeet

With a variety of different reasons for and against the development of biosimilars within the USA, generic manufacturers, originators and payers have differing views as to how this should come about. Visiongain is delighted to host the 4th Annual Biosimilars conference in Philadelphia this November. This 3-day event will provide you with practical insights into the scientific developments and regulatory challenges that will influence the success of biosimilars/follow-on biologics market. Enabling you with a platform to discuss the issues effecting the market, such as product selection and payer acceptance in a broader industry context. Consideration will be given to the evaluation of unwanted immunogenicity of follow-on biologicals, from preclinical development, through clinical trials, and into the post-registration period to minimise the risks associated with immunogenicity in recipients of therapeutic products. This meeting has received excellent feedback in previous years and this year’s programme will be no exception.